Clinical development
- SVF Vaccines reports positive data in Phase 1 study
21 Oct, 2024 - Launch of mRNA Cancer Vaccine Trial for Skin Cancer at Pascale Institute in Naples
21 Oct, 2024 - Allergy Therapeutics Launches Pediatric Trial for Allergy Vaccine
21 Oct, 2024 - Blue Lake Biotechnology and CyanVac Announce Presentation on Intranasal Vaccine Candidates at the International Society for Vaccines Annual Congress
21 Oct, 2024 - NIH Clinical Trial Shows Mpox Vaccine Safe for Adolescents
21 Oct, 2024 - Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine
21 Oct, 2024 - Kerala participates in ICMR’s phase-3 dengue vaccine trial | Tap to know more
20 Oct, 2024 - Yorkshire Coast Cancer Patients to Trial Personalised Cancer Vaccines
20 Oct, 2024 - Kerala joins ICMR’s landmark phase-3 clinical trial for indigenous dengue vaccine
19 Oct, 2024 - Sheffield bowel cancer patients to try out personalised ‘vaccines’
18 Oct, 2024 - FDA Places Clinical Hold on Novavax COVID-19/Influenza and Standalone Influenza Vaccine Trials
18 Oct, 2024 - Oral Norovirus Gastroenteritis Vaccine VXA-GI.1-NN Shows Efficacy
18 Oct, 2024 - MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win
18 Oct, 2024 - IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for Teens
17 Oct, 2024 - Bavarian Nordic’s mpox vaccine equally effective in teens as adults
17 Oct, 2024 - Fiocruz to Test First Leprosy Vaccine on Humans
17 Oct, 2024 - MSD’s CAPVAXIVE vaccine shows promise in pneumococcal disease trial
17 Oct, 2024 - UCD to lead major international trial of mpox vaccine
17 Oct, 2024 - New Vaccines in the Pipeline: Norovirus, Lyme Disease, and Combination COVID-19–Flu | IDWeek 2024
17 Oct, 2024 - World-First Marburg Vaccine Trial Underway in Rwanda
17 Oct, 2024 - Long term T cell response and safety of a tetravalent dengue vaccine in healthy children
17 Oct, 2024 - KFD vaccine likely to be available for use by 2026: Karnataka Health Minister
16 Oct, 2024 - First in-human HIV vaccine to induce virus-specific neutralizing antibodies
16 Oct, 2024 - Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
15 Oct, 2024 - Neurosurgeon Joseph Georges, P.I. for Diakonos Oncology’s Phase 1 Trial of Its Unique Dendritic Cell Vaccine for Gliobastoma, Receives the CNS 2024 Rosenblum-Mahaley Clinical Research Award
15 Oct, 2024 - Rift Valley fever vaccine to enter Phase II clinical trials in Kenya
15 Oct, 2024 - Approved Chikungunya Vaccine Confirmed Safe and Effective
15 Oct, 2024 - Indonesia Testing Tuberculosis Vaccine Candidates
15 Oct, 2024 - A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults
14 Oct, 2024
0 Comments